Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The New England Journal of Medicine|November 7, 2019
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and AdolescentsShibadas Biswal, Humberto Reynales, Xavier Saez-Llorens, et al.
Lancet (London, England)|March 21, 2020
Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trialShibadas Biswal, Charissa Borja-Tabora, Luis Martinez Vargas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2021
Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003)Luis Rivera, Shibadas Biswal, Xavier Sáez-Llorens, et al.
The Journal of Infectious Diseases|December 15, 2020
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after VaccinationEduardo López-Medina, Shibadas Biswal, Xavier Saez-Llorens, et al.
The Lancet. Global Health|January 20, 2024
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trialVianney Tricou, Delia Yu, Humberto Reynales, et al.
The Journal of Infectious Diseases|April 29, 2024
Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever VaccinationChukiat Sirivichayakul, Shibadas Biswal, Xavier Saez-Llorens, et al.
Lancet (London, England)|January 23, 2022
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trialLulu Bravo, Igor Smolenov, Htay Htay Han, et al.
Pageof 3